Ver Donck K. Pharm. World Sci. 16 (2), pp. 69-76, 1994. |
Forker et al, J. Clin. Pharmacol., 36;973-984 (1996). |
Sasayama et al, Heart and Vessels, 2:23-28 (1986). |
Feldman et al, Am. J. Cardiol, 68:1203-1210 (1991). |
"Effects of the Oral Cardiotonic Piperanometozine Upon Ischemic Myocardium", Shinzo (Cardiology), 20(6):670-678 (1988) (in Japanese and English Translations). |
"Effects of the Cardiovascular Agonist OPC-8212 Against Ischemic Heart Disease--Comparative Investigation with the .beta.-Blocker Metoprolol", 36(11):1199-1203 (1988) (in Japanese and English Translations). |
Maruyama et al, "Effects of OPC-8212, a New Positive Inotropic Agent, and Dobutamine on Left Ventricular Global and Ischemic Regional Functions and Coronary Hemodyamics Under Coronary Artery Stenosis", J. Cardiovasc. Pharmacol., 8(1):161-169 (1986). |
Takeya et al, "Positive Inotropic Effect of 3,4-Dihydro-6-�4-(3,4-Dimethoxybenzoyl)-1-Piperazinyl!-2(1H)-Quinolinone (OPC-8212) and Mechanism of Action in Guinea Pig Ventricular Myocardium", Arzneim.-Forsch./Drug Res., 34(1), Nr.3a:364-370 (1984). |